The Institute for Protein Design (IPD) was founded at the University of Washington with a core mission to create new proteins that address modern scientific and medical challenges. The institute focuses on pioneering research in protein design, offering services and tools that facilitate the development of novel proteins for therapeutic and industrial applications. Their market focus includes healthcare, biotechnology, and environmental sectors, aiming to revolutionize treatments and solutions through advanced protein engineering.
Notable affiliated individuals include David Baker, a prominent figure in the field of computational biology and protein design. The institute has garnered significant achievements, such as breakthroughs in COVID-19 therapeutics and innovative software tools for protein modeling. Supported by a robust advisory board and collaborations with leading researchers, IPD has made a substantial impact on scientific research and practical applications, positioning itself as a leader in the protein design landscape.
Quick Facts
When was Institute for Protein Design's last funding round?
Institute for Protein Design's most recent funding round was for $45M (USD) in April 2019.
How much disclosed funding has Institute for Protein Design raised?
As of Apr 16, 2019, Institute for Protein Design has disclosed funding of $56.3M (USD).
